AltheaDx Revenue and Competitors
Estimated Revenue & Valuation
- AltheaDx's estimated annual revenue is currently $2M per year.
- AltheaDx's estimated revenue per employee is $77,500
- AltheaDx's total funding is $83.4M.
Employee Data
- AltheaDx has 26 Employees.
- AltheaDx grew their employee count by -30% last year.
AltheaDx's People
Name | Title | Email/Phone |
---|---|---|
1 | COO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | SVP Sales and Marketing | Reveal Email/Phone |
4 | Senior Billing Manager | Reveal Email/Phone |
5 | Clinical Laboratory Supervisor | Reveal Email/Phone |
6 | Regional Sales Manager | Reveal Email/Phone |
AltheaDx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is AltheaDx?
AltheaDx is bringing cancer diagnostics into clinical use. The ultimate goal of AltheaDx is to win the war against cancer by reducing the time, risk, and cost of drug development and by providing comprehensive oncology testing services.
keywords:Biotechnology$83.4M
Total Funding
26
Number of Employees
$2M
Revenue (est)
-30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AltheaDx News
Castle Biosciences Inc. shares fall roughly 12% to $40.51 a day after the company said it signed a definitive agreement to acquire AltheaDx...
AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that are...
San Diego startup AltheaDx, which developed a molecular test designed to guide therapy for depression and anxiety based on a patient's genetics,...
SAN DIEGO, Aug. 18, 2021 /PRNewswire/ -- AltheaDx, a commercial stage, precision medicine company with a leading pharmacogenomics (PGx) test for anxiety and depression, announced today the expansion of its commercial leadership team with the appointment of Jonathan Yount, SVP of Sales. Jonatha ...
SAN DIEGO, June 7, 2021 /PRNewswire/ -- AltheaDx, a commercial stage precision medicine company with a leading pharmacogenomics test (PGx) for depression and anxiety is launching a series of webinars. These educational sessions will focus on the use of PGx testing and associated implications o ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.9M | 26 | -4% | N/A |
#2 | $1.8M | 26 | -24% | $13.8M |
#3 | $1.7M | 26 | -38% | $90.1M |
#4 | $3.8M | 26 | -51% | $35.5M |
#5 | $2.6M | 26 | N/A | N/A |